Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Large Lecture Theatre in Oxford's Sherrington building is being renamed the Blakemore Lecture Theatre in tribute to the longest serving Waynflete Professor of Physiology Sir Colin Blakemore FRS following a prestigious Festschrift event held in Professor Blakemore's honour.

Sir Colin Blakemore FRS

The Large Lecture Theatre is being renamed the Blakemore Lecture Theatre in recognition of the sustained and long-standing contribution of Professor Sir Colin Blakemore FRS as Waynflete Professor of Physiology (Department of Physiology, Anatomy & Genetics) and his time as an outstanding lecturer for generations of medical students and physiology students on the wonders of the brain.

Professor Blakemore is a world-renowned neuroscientist who has significantly contributed to our understanding of vision, and how the brain develops and adapts. He has been influential in demonstrating ‘neural plasticity’ — how brain cells reorganise themselves in response to the environment after birth and even in adulthood. Professor Blakemore joined the Department in October 1979 at the age of 35 years as the youngest Waynflete Chair of Physiology and a Professorial Fellowship at Magdalen College, positions he held until July 2007. During this time, he directed the McDonnell-Pew Centre for Cognitive Neuroscience and the Oxford Centre for Cognitive Neuroscience. From 2007-12, he was Professor of Neuroscience at the University of Oxford and Supernumerary Fellow at Magdalen. Professor Blakemore, who remains Emeritus Professor at DPAG, is also very well known for his passionate belief in the importance of public engagement with research. He has held several influential positions, including serving as Chief Executive of the Medical Research Council from 2003-07, and received a knighthood in 2014 for services to scientific research, policy and outreach.

Read the full story on the Department of Physiology, Anatomy & Genetics website.

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.